genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
01 April 2019
Interim Presentation 31 December 2018
View all reports >
Thursday May 23, 2019
Genedrive making commercial progress
Friday March 29, 2019
Peel Hunt resumes coverage of Genedrive with a ‘buy’ rating and 60p price target after recent results
Thursday March 28, 2019
Genedrive optimistic about some near-term progress on its Genedrive HCV ID registrations
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-19 genedrive plc
Don't show this again